Stay informed with the latest updates for the inheritable blood disorders community. IndustryBaxter Seeks Pediatric Indication from FDA for RIXUBISJan 1, 2014 Advocacy & LegislativeNew Year, Newly InsuredJan 1, 2014 MedicalBaxter Receives FDA Approval for FEIBA for Prophylactic…Jan 1, 2014 NBDF & CommunityIdaho HTC Hosts Grant Award PresentationJan 1, 2014 MedicalNovo Receives FDA Approval for rFXIII TherapyJan 1, 2014 MedicalFDA Approves Gilead's Sovaldi, First Interferon-sparing HCV TherapyJan 1, 2014 IndustryEnrollment Complete for Baxter's PROLONG-ATE StudyDec 1, 2013 MedicalFDA Approves Simeprevir, New HCV Oral Therapy; Approval Pending for…Dec 1, 2013 IndustryProgress and Delay for Biogen's Longer-Lasting rFVIII TherapyDec 1, 2013 Advocacy & LegislativeNHF Partners with PSI in the CAC ProgramDec 1, 2013 Advocacy & LegislativeACA Implementation Continues Amid Website WoesDec 1, 2013 MedicalHematology Researchers Elected to IOMNov 1, 2013 IndustryFDA Approves BLA for Novo Nordisk's New rFVIII ProductNov 1, 2013 NBDF & CommunityMASAC Issues New and Updated DocumentsNov 1, 2013 Advocacy & LegislativeUpdated Personal Health Insurance Toolkits AvailableNov 1, 2013 Pagination First page Previous page … Page 73 Page 74 Page 75 Page 76 Current page 77 Page 78 Page 79 Page 80 Page 81 … Next page Last page
